Pemetrexed and carboplatin in the treatment of malignant pleural mesothelioma (MPM)

被引：0
|
作者：
Papi, M.
Genestreti, G.
Tassinari, D.
Tamburini, E.
Nicoletti, S.
Nicolini, M.
Fabbri, P.
Fabbri, P.
Santo, A.
Pasquini, E.
Ravaioli, A.
机构：
[1] City Hosp, Rimini, Italy
[2] City Hosp, Forli, Italy
[3] City Hosp, Cattolica, Italy
[4] City Hosp, Verona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18114
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Santoro, A.
    Ceresoli, G. L.
    Marangolo, M.
    Mencoboni, M.
    Zucali, P.
    Favaretto, A.
    Grossi, F.
    Bearz, A.
    Botta, M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S18 - S18
  • [2] Pemetrexed plus Carboplatin or Cisplatin as Neoadjuvant Treatment of Operable Malignant Pleural Mesothelioma (MPM)
    Pasello, Giulia
    Marulli, Giuseppe
    Polo, Valentina
    Breda, Cristiano
    Bonanno, Laura
    Loreggian, Lucio
    Rea, Federico
    Favaretto, Adolfo
    [J]. ANTICANCER RESEARCH, 2012, 32 (12) : 5393 - 5399
  • [3] Pemetrexed (MTA) and carboplatin (CBDCA) in the treatment of advanced pleural mesothelioma (MPM).
    Castagneto, B.
    Mencoboni, M.
    Degiovanni, D.
    Muzio, A.
    Giaretto, L.
    Rebella, L.
    Alabiso, O.
    Buosi, R.
    Cafferata, M.
    Botta, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 387S - 387S
  • [4] Pemetrexed (MTA) and carboplatin (CBDCA) in the treatment of advanced pleural mesothelioma (MPM)
    Castagneto, B.
    Aitini, E.
    Botta, M.
    Degiovanni, D.
    Muzio, A.
    Pari, F.
    Tredici, S.
    Buosi, R.
    Cafferata, M.
    Alabiso, O.
    Mencoboni, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI86 - XI86
  • [5] Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Botta, M.
    Aitini, E.
    Spigno, F.
    Degiovanni, D.
    Alabiso, O.
    Serra, M.
    Muzio, A.
    Carbone, R.
    Buosi, R.
    Galbusera, V.
    Piccolini, E.
    Giaretto, L.
    Rebella, L.
    Mencoboni, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (02) : 370 - 373
  • [6] PEMETREXED IN COMBINATION WITH CARBOPLATIN IN THE TREATMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA
    Pasquini, E.
    Papi, M.
    Drudi, F.
    Tamburini, E.
    Genestreti, G.
    Nicoletti, S.
    Arcangeli, V
    Nicolini, M.
    Fabbri, P.
    Santo, A.
    Gianni, L.
    Fantini, M.
    Ravaioli, A.
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [7] Malignant pleural mesothelioma in 2008. Beyond pemetrexed, what treatment is there for MPM?
    Zalcman, G.
    [J]. REVUE DE PNEUMOLOGIE CLINIQUE, 2008, 64 : 38 - 40
  • [8] Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: A realistic treatment option?
    Li, Louise
    Razak, Albiruni Ryan Abdul
    Hughes, Andrew
    [J]. LUNG CANCER, 2009, 64 (02) : 207 - 210
  • [9] PEMETREXED/CARBOPLATIN(AC) OR PEMETREXED/CISPLATIN (AP) AS FIRST LINE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA (MPM): TOLERABILITY AND RESPONSE RATE IN OPERABLE PATIENTS
    Pasello, Giulia
    Marulli, Giuseppe
    Nicotra, Samuele
    Rea, Federico
    Loreggian, Lucio
    Bonanno, Laura
    Favaretto, Adolfo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1367 - S1368
  • [10] Pemetrexed for malignant pleural mesothelioma (MPM): updated experience in Northern Ireland
    Fenton, A.
    Harney, J.
    Stewart, D.
    Scullin, P.
    [J]. LUNG CANCER, 2011, 71 : S16 - S16
12345